CSF biomarkers for secondary prevention trials: why markers of amyloid deposition and neurodegeneration are both important
| Image |  |
|---|---|
| Description | scientific article published on 01 June 2012 |
| Author/s |
author: David M. Holtzman |
| Publication date | June 1, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |